233 related articles for article (PubMed ID: 19346028)
41. Carboplatin-pemetrexed adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): a phase II study.
Karapanagiotou EM; Boura PG; Papamichalis G; Konstantinou M; Sepsas E; Chamalakis G; Simsiris P; Gkiozos I; Syrigos KN
Anticancer Res; 2009 Oct; 29(10):4297-301. PubMed ID: 19846990
[TBL] [Abstract][Full Text] [Related]
42. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma.
Galsky MD; Mironov S; Iasonos A; Scattergood J; Boyle MG; Bajorin DF
Invest New Drugs; 2007 Jun; 25(3):265-70. PubMed ID: 17146733
[TBL] [Abstract][Full Text] [Related]
43. [Pemetrexed: from preclinic to clinic].
Lansiaux A; Lokiec F
Bull Cancer; 2007; 94 Spec No Actualites():S134-8. PubMed ID: 17845983
[TBL] [Abstract][Full Text] [Related]
44. A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncology.
Miller DS; Blessing JA; Drake RD; Higgins R; McMeekin DS; Puneky LV; Krasner CN
Gynecol Oncol; 2009 Dec; 115(3):443-6. PubMed ID: 19804902
[TBL] [Abstract][Full Text] [Related]
45. [Long-term survival of patient with brain metastases from lung cancer treated by pemetrexed monotherapy].
Ito S; Ogawa Y; Harada H; Yamaguchi T; Munakata K
Gan To Kagaku Ryoho; 2012 May; 39(5):793-6. PubMed ID: 22584333
[TBL] [Abstract][Full Text] [Related]
46. Pemetrexed-induced anaphylaxis.
Shah BK; Hewett Y
Acta Oncol; 2013 May; 52(4):881. PubMed ID: 23472834
[No Abstract] [Full Text] [Related]
47. [Bronchiolar-alveolar carcinoma: From concept to innovative therapeutic strategies].
Wislez M; Lavolé A; Gounant V; Antoine M; Cadranel J
Presse Med; 2011 Apr; 40(4 Pt 1):389-97. PubMed ID: 21419590
[TBL] [Abstract][Full Text] [Related]
48. [Pemetrexed development in oncology].
Chaigneau L; Villanueva C; Thierry-Vuillemin A; Legat-Fagnoni C; N'Guyen T; Maurina T; Lorgis V; Pivot X
Bull Cancer; 2007; 94 Spec No Actualites():S142-8. PubMed ID: 17845985
[TBL] [Abstract][Full Text] [Related]
49. Pemetrexed-induced skin sclerosis.
Merklen-Djafri C; Imbert E; Courouge-Dorcier D; Schott R; Méraud JP; Muller C; Tebacher M; Springinsfeld G; Cribier B; Lipsker D
Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):452-3. PubMed ID: 22397832
[No Abstract] [Full Text] [Related]
50. Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features.
Wislez M; Antoine M; Rabbe N; Gounant V; Poulot V; Lavolé A; Fleury-Feith J; Cadranel J
Clin Cancer Res; 2007 Jun; 13(12):3518-27. PubMed ID: 17575214
[TBL] [Abstract][Full Text] [Related]
51. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database.
Read WL; Page NC; Tierney RM; Piccirillo JF; Govindan R
Lung Cancer; 2004 Aug; 45(2):137-42. PubMed ID: 15246183
[TBL] [Abstract][Full Text] [Related]
52. A new era for bronchioloalveolar carcinoma: current state of the art and recent advances in biologically targeted therapy.
Johal BS; Laskin J
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1411-9. PubMed ID: 17069526
[TBL] [Abstract][Full Text] [Related]
53. Pemetrexed-induced typhlitis in non-small cell lung cancer.
Shvartsbeyn M; Edelman MJ
J Thorac Oncol; 2008 Oct; 3(10):1188-90. PubMed ID: 18827618
[TBL] [Abstract][Full Text] [Related]
54. Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy.
Villela LR; Stanford BL; Shah SR
Pharmacotherapy; 2006 May; 26(5):641-54. PubMed ID: 16637794
[TBL] [Abstract][Full Text] [Related]
55. [Modern diagnostic and therapeutic methods in bronchiolo-alveolar carcinoma].
Aleksandrović J; Jeremić B
Srp Arh Celok Lek; 1997; 125(11-12):356-62. PubMed ID: 9480571
[TBL] [Abstract][Full Text] [Related]
56. Pemetrexed-induced eyelid edema in lung cancer.
Martins-Filho PR; Kameo SY; Mascarenhas-Oliveira AC; Vieira NF; Azevedo E
J Craniofac Surg; 2013 Jul; 24(4):e401-3. PubMed ID: 23851735
[TBL] [Abstract][Full Text] [Related]
57. [Assessment of risk factors for adverse events due to pemetrexed in patients with reduced renal function].
Kono M; Sakata Y; Sugawara T; Abe K; Miyamori S; Miura S; Hata Y; Funaki M; Inata J; Kanehara M; Hiraki K; Iwamoto Y
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2587-90. PubMed ID: 25596053
[TBL] [Abstract][Full Text] [Related]
58. Severe immune hemolytic anemia due to pemetrexed in a patient with non-small cell lung cancer.
Sun X; Sheng L; Deng Q; Liu P; Lu K
Pharmacology; 2011; 88(5-6):242-4. PubMed ID: 21997597
[TBL] [Abstract][Full Text] [Related]
59. Bronchioloalveolar carcinoma.
Arenberg D
Semin Respir Crit Care Med; 2011 Feb; 32(1):52-61. PubMed ID: 21500124
[TBL] [Abstract][Full Text] [Related]
60. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
Jian Z; Tomizawa Y; Yanagitani N; Iijima H; Sano T; Nakajima T
Pathol Int; 2005 Oct; 55(10):619-25. PubMed ID: 16185291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
